Apimeds Pharmaceuticals US, Inc.
APUS
$1.63
-$0.15-8.43%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7,051.43% | -86.84% | -57.98% | -57.06% | -64.09% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.00% | -6.80% | -- | -- | -11.21% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1,883.97% | -64.50% | -49.93% | -53.27% | -62.64% |
|
|
|||||
| Total Current Assets | 1,883.97% | -64.50% | -49.93% | -53.27% | -62.64% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1,883.97% | -64.50% | -49.93% | -53.27% | -62.64% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 50.92% | 37.15% | 31.34% | 185.90% | 9.89% |
| Short-term Debt | 5.27% | 30.60% | 150.00% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 225.00% | -20.00% | -- |
| Total Other Current Liabilities | -- | -- | 225.00% | -20.00% | -- |
| Total Current Liabilities | 72.84% | 34.53% | 55.96% | 257.66% | 10.71% |
|
|
|||||
| Total Current Liabilities | 72.84% | 34.53% | 55.96% | 257.66% | 10.71% |
| Long-Term Debt | -27.91% | 7.70% | 7.51% | 4.79% | 7.08% |
| Short-term Debt | 5.27% | 30.60% | 150.00% | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 47.35% | 26.56% | 37.56% | 86.50% | 8.23% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Retained Earnings | -9.16% | -7.64% | -8.87% | -13.62% | -9.88% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -29.63% | -29.78% | -46.57% | -169.84% | -929.47% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -29.63% | -29.78% | -46.57% | -169.84% | -929.47% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -29.63% | -29.78% | -46.57% | -169.84% | -929.47% |
|
|
|||||